OptiNose, Inc. (OPTN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.1300 |
| Open | 1.1500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.0900 - 1.1500 |
| 52-week range | 0.8000 - 2.1000 |
| Volume | |
| Avg. volume | 1,215,152 |
| Market cap | 125.473M |
| Beta (5Y monthly) | -0.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2700 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.50 |
GlobeNewswireOptinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A
- GuruFocus.com
OptiNose Inc (OPTN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
Amidst robust revenue growth and operational efficiencies, OptiNose Inc (OPTN) sets a positive trajectory for 2024.
© 2024 Yahoo. All rights reserved.